Literature DB >> 1977310

Haplotype analysis of the human apolipoprotein B mutation associated with familial defective apolipoprotein B100.

E H Ludwig1, B J McCarthy.   

Abstract

Haplotype analysis was conducted on the mutant allele of 14 unrelated subjects heterozygous for a mutation in the codon for amino acid 3500 of human apolipoprotein B100. This mutation is associated with defective binding of low-density lipoprotein to the low-density lipoprotein receptor and with moderate hypercholesterolemia. Ten markers were used for haplotyping: eight diallelic markers within the structural gene and two hypervariable loci flanking the gene. Seven of eight unequivocally deduced haplotypes were identical, and one revealed only a minor difference at one of the hypervariable loci. The genotypes of the six other affected subjects were consistent with this same assigned haplotype. These data are consistent with a common ancestral chromosome and provide no evidence for a recurrent mutation at this potentially hypermutable CG dinucleotide, despite the fact that this mutation is not rare.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1977310      PMCID: PMC1683798     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  31 in total

1.  Analysis of the human alpha-globin gene cluster reveals a highly informative genetic locus.

Authors:  D R Higgs; J S Wainscoat; J Flint; A V Hill; S L Thein; R D Nicholls; H Teal; H Ayyub; T E Peto; A G Falusi
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

2.  Variable number of tandem repeat (VNTR) markers for human gene mapping.

Authors:  Y Nakamura; M Leppert; P O'Connell; R Wolff; T Holm; M Culver; C Martin; E Fujimoto; M Hoff; E Kumlin
Journal:  Science       Date:  1987-03-27       Impact factor: 47.728

3.  The same "TATA" box beta-thalassemia mutation in Chinese and US blacks: another example of independent origins of mutation.

Authors:  S Huang; C Wong; S E Antonarakis; T Ro-lien; W H Lo; H H Kazazian
Journal:  Hum Genet       Date:  1986-10       Impact factor: 4.132

4.  In vivo evidence for reduced binding of low density lipoproteins to receptors as a cause of primary moderate hypercholesterolemia.

Authors:  G L Vega; S M Grundy
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

5.  Hypervariable 'minisatellite' regions in human DNA.

Authors:  A J Jeffreys; V Wilson; S L Thein
Journal:  Nature       Date:  1985 Mar 7-13       Impact factor: 49.962

Review 6.  The mutation and polymorphism of the human beta-globin gene and its surrounding DNA.

Authors:  S H Orkin; H H Kazazian
Journal:  Annu Rev Genet       Date:  1984       Impact factor: 16.830

Review 7.  DNA polymorphism and molecular pathology of the human globin gene clusters.

Authors:  S E Antonarakis; H H Kazazian; S H Orkin
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

8.  Linkage of beta-thalassaemia mutations and beta-globin gene polymorphisms with DNA polymorphisms in human beta-globin gene cluster.

Authors:  S H Orkin; H H Kazazian; S E Antonarakis; S C Goff; C D Boehm; J P Sexton; P G Waber; P J Giardina
Journal:  Nature       Date:  1982-04-15       Impact factor: 49.962

9.  Apolipoprotein B-gene DNA polymorphisms associated with myocardial infarction.

Authors:  R A Hegele; L S Huang; P N Herbert; C B Blum; J E Buring; C H Hennekens; J L Breslow
Journal:  N Engl J Med       Date:  1986-12-11       Impact factor: 91.245

Review 10.  Construction of a genetic linkage map in man using restriction fragment length polymorphisms.

Authors:  D Botstein; R L White; M Skolnick; R W Davis
Journal:  Am J Hum Genet       Date:  1980-05       Impact factor: 11.025

View more
  9 in total

1.  First International Workshop on Familial Defective apo B-100, Munich, November 1991.

Authors:  H Schuster; S Humphries; G Rauh; C Keller
Journal:  Clin Investig       Date:  1992-10

2.  Absence of familial defective apolipoprotein B-100 in Israeli patients with dominantly inherited hypercholesterolemia and in offspring with parental history of myocardial infarction.

Authors:  Y Friedlander; E J Dann; E Leitersdorf
Journal:  Hum Genet       Date:  1993-04       Impact factor: 4.132

3.  Identification of a heterozygous compound individual with familial hypercholesterolemia and familial defective apolipoprotein B-100.

Authors:  G Rauh; H Schuster; J Fischer; C Keller; G Wolfram; N Zöllner
Journal:  Klin Wochenschr       Date:  1991-05-03

4.  Complete paternal isodisomy for chromosome 8 unmasked by lipoprotein lipase deficiency.

Authors:  P Benlian; L Foubert; E Gagné; L Bernard; J L De Gennes; S Langlois; W Robinson; M Hayden
Journal:  Am J Hum Genet       Date:  1996-08       Impact factor: 11.025

Review 5.  Familial defective apolipoprotein B-100: a common cause of primary hypercholesterolemia.

Authors:  G Rauh; C Keller; H Schuster; G Wolfram; N Zöllner
Journal:  Clin Investig       Date:  1992-01

6.  Two amino acid substitutions in apolipoprotein B are in complete allelic association with the antigen group (x/y) polymorphism: evidence for little recombination in the 3' end of the human gene.

Authors:  A M Dunning; H H Renges; C F Xu; R Peacock; R Brasseur; G Laxer; M J Tikkanen; R Bütler; N Saha; A Hamsten
Journal:  Am J Hum Genet       Date:  1992-01       Impact factor: 11.025

7.  No evidence for linkage between familial hypertriglyceridemia and apolipoprotein B, apolipoprotein C-III or lipoprotein lipase genes.

Authors:  T Heliö; A Palotie; T Sane; M J Tikkanen; K Kontula
Journal:  Hum Genet       Date:  1994-09       Impact factor: 4.132

8.  Familial ligand-defective apolipoprotein B. Identification of a new mutation that decreases LDL receptor binding affinity.

Authors:  C R Pullinger; L K Hennessy; J E Chatterton; W Liu; J A Love; C M Mendel; P H Frost; M J Malloy; V N Schumaker; J P Kane
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

Review 9.  The roles of genetic polymorphisms and human immunodeficiency virus infection in lipid metabolism.

Authors:  Elaine Regina Delicato de Almeida; Edna Maria Vissoci Reiche; Ana Paula Kallaur; Tamires Flauzino; Maria Angelica Ehara Watanabe
Journal:  Biomed Res Int       Date:  2013-11-12       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.